1. Globocan 2018: India factsheet . India Against Cancer. http://cancerindia.org.in/globocan-2018-india-factsheet/. Updated 2020. Accessed 15 March 2020.
Google Scholar2. Thakur, JS, Budukh, A, Kapoor, R, et al. Urban–rural differences in cancer incidence and pattern in Punjab and Chandigarh: findings from four new population-based cancer registries in North India. Int J Non-Commun Dis. 2017;2:49-55. doi:10.4103/jncd.jncd_11_17.
Google Scholar | Crossref3. Mangat, C, Goel, NK, Walia, DK, et al. Metabolic syndrome: a challenging health Issue in highly urbanized Union Territory of north India. Diabetol Metab Syndr. 2010;2:19-27. doi:10.1186/1758-5996.
Google Scholar | Crossref | Medline4. Sharma, S, Aggarwal, N, Joshi, B, Suri, V, Badada, S. Prevalence of metabolic syndrome in pre- and post-menopausal women: a prospective study from apex institute of North India. J Midlife Health. 2016;7:169-174. doi:10.4103/0976-7800.195695.
Google Scholar | Crossref | Medline5. Sinagra, D, Amato, C, Scarpilta, AM, et al. Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci. 2002;6:55-59.
Google Scholar | Medline6. Iversen, A, Thune, I, McTiernan, A, et al. Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study. Hum Reprod. 2011;26:1519-1529. doi:10.1093/humrep/der081.
Google Scholar | Crossref | Medline7. Agnoli, C, Berrino, F, Abagnato, CA, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case control study. Nutr Met Cardiovasc Dis. 2010;20:41-48. doi:10.1016/j.numecd.2009.02.006.
Google Scholar | Crossref | Medline | ISI8. Conroy, S, Butler, L, Harvey, D, et al. Metabolic syndrome and mammographic density: the study of women’s health across the nation. Int J Cancer. 2011;129:1699-1707. doi:10.1158/1940-6207.
Google Scholar | Crossref | Medline9. Tehranifar, P, Reynolds, D, Fan, X, et al. Multiple metabolic risk factors and mammographic breast density. Ann Epidemiol. 2014;24:479-483. doi:10.1016/j.annepidem.2014.02.011.
Google Scholar | Crossref | Medline10. Kim, B, Chang, Y, Ahn, J, et al. Metabolic syndrome, insulin resistance, and mammographic density in pre- and postmenopausal women. Breast Cancer Res Treat. 2015;153:425-434. doi:10.1007/s10549-015.
Google Scholar | Crossref | Medline11. Tehranifar, P, Protacio, A, Schmitt, K, et al. The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women. Cancer Causes Control. 2015;26:1393-1403. doi:10.1007/s10552-015.
Google Scholar | Crossref | Medline12. Healy, L, Ryan, A, Carroll, P, et al. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol. 2010;22:281-288. doi:10.1016/j.clon.2010.02.001.
Google Scholar | Crossref13. Maiti, B, Kundranda, M, Spiro, T, Daw, H. The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat. 2009;121:479-483. doi:10.1007/s10549-009.
Google Scholar | Crossref | Medline14. Agresti, R, Meneghini, E, Baili, P, et al. Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study. Breast Cancer Res Treat. 2016;157:179-189. doi:10.1007/s10549-016.
Google Scholar | Crossref | Medline15. Can, A, Alacacioglu, A, Kucukzeybek, Y, et al. The relationship of insulin resistance and metabolic breast cancer prognostic factors in postmenopausal breast cancer patients. J Buon. 2013;18:845-850.
Google Scholar | Medline16. Calip, G, Malone, K, Gralow, J, Stergachis, A, Hubbard, R, Boudreau, D. Metabolic syndrome and outcomes following early-stage breast cancer. Breast Cancer Res Treat. 2014;148:363-377. doi:10.1007/s10549-014.
Google Scholar | Crossref | Medline17. Fan, Y, Ding, X, Wang, J, et al. Decreased serum HDL at initial diagnosis correlates with worse outcomes for triple-negative breast cancer but not non-TNBCs. Int J Biol Markers. 2015;30:e200-e207. doi:10.5301/jbm.5000143.
Google Scholar | SAGE Journals | ISI18. Kate, A, Kadambari, D. Incidence of metabolic syndrome in breast cancer survivors on adjuvant hormonal therapy. J Pharmacol Pharmacother. 2016;7:28-30. doi:10.4103/0976-500X.179362.
Google Scholar | Crossref | Medline19. Bradshaw, P, Ibrahim, J, Stevens, J, et al. Postdiagnosis change in bodyweight and survival after breast cancer diagnosis. Epidemiology. 2012;23:320-327. doi:10.1097/EDE.0b013e31824596a1.
Google Scholar | Crossref | Medline20. Playdon, M, Bracken, M, Sanft, T, Ligibel, J, Harrigan, M, Irwin, M. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst. 2015;107:djv275. doi:10.1093/jnci/djv275.
Google Scholar | Crossref | Medline21. Alberti Zimmet, P, Shaw, J. Metabolic syndrome – a new world-wide definition. Diabet Med. 2006;23:469-480. doi:10.1111/j.1464-5491.2006.01858.x.
Google Scholar | Crossref | Medline22. Jeffers, A, Sieh, W, Lipson, J, et al. Breast cancer risk and mammographic density assessed with semiautomated and fully automated methods and BI-RADS. Radiology. 2017;282:348-355. doi:10.1148/radiol.2016152062.
Google Scholar | Crossref | Medline23. Guiu, S, Michiels, S, Andre, F, et al. Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol. 2012;23:2997-3006. doi:10.1093/annonc/mds586.
Google Scholar | Crossref | Medline | ISI24. Bhandari, R, Kelley, G, Hartley, T, Rockett, I. Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis. Int J Breast Cancer. 2014;2014:189384. doi:10.1155/2014/189384.
Google Scholar | Crossref | Medline